Zelluna – medical illustration
Mechanism of action illustration
Our medical illustration explaining the mechanism of action of CD4+ and CD9+ cells against tumour cells.
Client
Zelluna Immunotherapy is a Norwegian biotech company developing immunotherapy treatments against solid tumors using TCRs derived from CD4 and CD8 T cells.
Find out more on Zelluna’s website.